Cargando…
SETD2 mutation in renal clear cell carcinoma suppress autophagy via regulation of ATG12
Inactivating mutations in the SETD2 gene, encoding for a nonredundant histone H3 methyltransferase and regulator of transcription, is a frequent molecular feature in clear cell renal cell carcinomas (ccRCC). SETD2 deficiency is associated with recurrence of ccRCC and bears low prognostic values. Tar...
Autores principales: | González-Rodríguez, Patricia, Engskog-Vlachos, Pinelopi, Zhang, Hanzhao, Murgoci, Adriana-Natalia, Zerdes, Ioannis, Joseph, Bertrand |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6985262/ https://www.ncbi.nlm.nih.gov/pubmed/31988284 http://dx.doi.org/10.1038/s41419-020-2266-x |
Ejemplares similares
-
SETD2 transcriptional control of ATG14L/S isoforms regulates autophagosome–lysosome fusion
por: González-Rodríguez, Patricia, et al.
Publicado: (2022) -
Proteome integral solubility alteration high-throughput proteomics assay identifies Collectin-12 as a non-apoptotic microglial caspase-3 substrate
por: Grabert, Kathleen, et al.
Publicado: (2023) -
ULK3-dependent activation of GLI1 promotes DNMT3A expression upon autophagy induction
por: González-Rodríguez, Patricia, et al.
Publicado: (2022) -
Histone methyltransferase SETD2: An epigenetic driver in clear cell renal cell carcinoma
por: Yu, Mengxue, et al.
Publicado: (2023) -
The DNA methyltransferase DNMT3A contributes to autophagy long-term memory
por: González-Rodríguez, Patricia, et al.
Publicado: (2020)